Agios Pharmaceuticals | AGIO - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
AbbVie USD 3.59B 28.65B 2025-12
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 19.52B 1.37B 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
AstraZeneca USD 22.89B 388M 2026-06
Bayer EUR 6.59B 496M 2026-03
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Daiichi Sankyo JPY 539.05B 57.81B 2026-06
Eli Lilly USD 5.03B 350M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Merck USD 3.86B 541M 2026-03
Moderna USD 167M 6M 2026-06
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03